CAS 1001600-56-1

BV6

CAS: 1001600-56-1

BV6

Formula: C₇₀H₉₆N₁₀O₈

Purity: ≥95%

Molecular weight: 1205.57

Ref: 54-BUP09225

BV6

CAS: 1001600-56-1

BV6 is an antagonist of c-IAP1 and XIAP, members of the inhibitors of apoptosis (IAP) family.

Formula: C₇₀H₉₆N₁₀O₈

Purity: 97.46% - 99.82%

Color and Shape: Solid

Molecular weight: 1205.57

Ref: TM-T6428

BV6

CAS: 1001600-56-1

(2S,2'S)-N,N'-((2S,2'S)-(Hexane-1,6-diylbis(azanediyl))bis(1-oxo-3,3-diphenylpropane-1,2-diyl))bis(1-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide)

Formula: C₇₀H₉₆N₁₀O₈

Purity: 99%

Molecular weight: 1205.57

Ref: IN-DG629814

BV-6

Controlled Product

CAS: 1001600-56-1

Formula: C₇₀H₉₆N₁₀O₈

Color and Shape: Neat

Molecular weight: 1205.6

Ref: TR-B810530

BV6

CAS: 1001600-56-1

BV6 is a mouse tumor that has been shown to be clinically relevant in vivo. It induces necrotic cell death, which has been shown to be TNFR-related apoptosis-inducing and apoptosis protein-mediated. BV6 also induces mitochondrial membrane potential and chemoattractant protein release, both of which are involved in the pathogenesis of tumor cells. This compound induces fatty acid production, which may be a potential biomarker for primary sclerosing cholangitis and colorectal cancer. Monoclonal antibodies have been developed to treat this tumor, as well as other types of tumors.

Formula: C₇₀H₉₆N₁₀O₈

Purity: Min. 95%

Molecular weight: 1,205.59 g/mol

Ref: 3D-BQB60056